SynthesisInternational wound journal2026
The Use of Adipose Derived Stem Cells in Chronic Wound Healing.
Synthesis in International wound journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wound healing is a complex process of angiogenesis, inflammation and proliferation relying on co-ordination of multiple cell types and cytokines. Dysregulation of this process can lead to chronicity, which we are seeing more commonly due to an increasingly comorbid population. Adipose-Derived Stem Cells (ADSCs) show promise as a therapy though their ability to augment the tissue microenvironment via multiple pathways. This review aims to synthesise evidence on the effects of ADSCs on chronic wound healing to assess their efficacy. A systematic search of four databases was conducted covering a period up to June 2025. Comparative studies investigating ADSCs and wounds of any aetiology were included, and a meta-analysis was performed on pooled data. Ten studies were included in the meta-analysis (N = 498). Patients treated with ADSCs were more likely to heal at short-term follow-up (odds ratio (OR) 6.54, 95% confidence interval (CI) 3.80-11.27; n = 377 I
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.